Bilayer dissolving microneedle array containing 5-fluorouracil and triamcinolone with biphasic release profile for hypertrophic scar therapy
Beibei Yang(Second Affiliated Hospital of Zhejiang University), Chuanbin Wu(Sun Yat-sen University), Guilan Quan(Jinan University), Yifeng Shen(Sun Yat-sen University), Yating Dong(Sun Yat-sen University), Xin Pan(Sun Yat-sen University), Ailin Hou(Sun Yat-sen University)
Cited by 114
Related Papers
Application of glutathione depletion in cancer therapy: Enhanced ROS-based therapy, ferroptosis, and chemotherapy
|Biomaterials|2021|1.1k
Mesoporous silica nanoparticles for drug and gene delivery
|Acta Pharmaceutica Sinica B|2018|691
Microneedle-mediated transdermal drug delivery for treating diverse skin diseases
|Acta Biomaterialia|2020|247
Membrane-disruptive peptides/peptidomimetics-based therapeutics: Promising systems to combat bacteria and cancer in the drug-resistant era
|Acta Pharmaceutica Sinica B|2021|176
Strategy for hypertrophic scar therapy: Improved delivery of triamcinolone acetonide using mechanically robust tip-concentrated dissolving microneedle array
|Journal of Controlled Release|2019|153